• $8.0M
    Market Cap
  • -99.07%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
Income Statement
Total Operating Revenue
590,084
N/A
N/A
N/A
1.7M
N/A
Cost of Revenue
404,770
N/A
N/A
N/A
578,015
N/A
Gross Profit
185,314
N/A
0
-100.00%
1.1M
N/A
Sales and Marketing Expense
200,940
-31.31%
292,522
-55.70%
660,291
N/A
Research and Development Expense
-147,010
+40.47%
-104,654
-75.45%
-426,243
N/A
Depreciation and Amortization Expense
96,663
+646.43%
12,950
+11.17%
11,649
N/A
Total Operating Expenses
7.1M
+92.91%
3.7M
-25.25%
4.9M
N/A
Operating Profit
-7.7M
+24.08%
-6.2M
+45.20%
-4.3M
N/A
Interest Income
118,030
+815.60%
12,891
+131.69%
5,564
N/A
Interest Expense
-103,294
N/A
N/A
N/A
-19,525
N/A
Interest Income and Expense and Net
14,736
+14.31%
12,891
+192.34%
-13,961
N/A
Total Nonoperating Income and Expense
33,079
+109.37%
-353,148
-90.62%
-3.8M
N/A
Income before Taxes
-7.7M
+24.08%
-6.2M
+45.20%
-4.3M
N/A
Income Taxes
30,972
N/A
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-7.7M
+24.05%
-6.2M
+45.20%
-4.3M
N/A
Net Income from Continuing Operations Applicable to Common
-7.8M
+93.71%
-4.0M
-6.62%
-4.3M
N/A
Basic EPS and Net Income
N/A
N/A
N/A
N/A
-0.40
N/A
Diluted EPS and Net Income
N/A
N/A
N/A
N/A
-0.40
N/A
Basic Weighted Average Shares
20,352
-74.43%
79,582
-99.26%
10.7M
N/A
Diluted Weighted Average Shares
20,352
-74.43%
79,582
-99.26%
10.7M
N/A
Balance Sheet
Cash and Cash Equivalents
5.4M
+35.59%
4.0M
+19.77%
3.3M
N/A
Short-Term Investments
572,054
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
6.0M
+49.94%
4.0M
+19.77%
3.3M
N/A
Total Current Assets
6.9M
+13.56%
6.1M
+23.00%
4.9M
N/A
Accumulated Depreciation
6,534
+331.57%
1,514
-90.38%
15,732
N/A
Property and Plant and Equipment and Net
885,520
+81,364.58%
1,087
-97.95%
53,119
N/A
Total Long-Term Assets
885,520
+531.74%
140,171
+163.88%
53,119
N/A
Total Assets
12.9M
+43.09%
9.0M
+73.28%
5.2M
N/A
Income Taxes Payable
30,972
N/A
N/A
N/A
73,228
N/A
Total Short-Term Debt
1.3M
+458.12%
240,000
N/A
N/A
N/A
Total Current Liabilities
3.9M
+119.12%
1.8M
+38.68%
1.3M
N/A
Total Long-Term Debt
85,000
N/A
N/A
N/A
183,970
N/A
Total Long-Term Liabilities
1.1M
+109.51%
534,467
+716.12%
65,489
N/A
Total Liabilities
5.0M
+115.59%
2.3M
+71.23%
1.4M
N/A
Retained Earnings
-21.0M
+58.39%
-13.3M
+88.92%
-7.0M
N/A
Total Stockholders Equity
7.8M
+17.69%
6.7M
+74.01%
3.8M
N/A
Total Shares Outstanding
80,699
-81.62%
438,987
-97.47%
17.3M
N/A
Cash Flow
Cash from Operating Activities
-5.9M
+8.14%
-5.5M
+20.41%
-4.6M
N/A
Capital Expenditures
442,255
+4,728.11%
9,160
N/A
N/A
N/A
Cash from Investing Activities
-2.8M
+352.89%
-610,564
+5,355.85%
-11,191
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
10.1M
+49.71%
6.8M
+0.28%
6.7M
N/A
Financials Ratio
Gross Margin
31.40%
N/A
N/A
N/A
N/A
N/A
Operating Margin
-1,313.33%
N/A
N/A
N/A
N/A
N/A
Return on Assets
-70.88%
-19.52%
-88.07%
N/A
N/A
N/A
Return on Equity
-106.89%
-10.27%
-119.12%
N/A
N/A
N/A
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
1.74
-48.18%
3.36
N/A
N/A
N/A
Cash Ratio
1.37
-38.12%
2.21
N/A
N/A
N/A
Debt-to-Equity Ratio
0.18
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
0.11
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow